Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective

被引：41

作者：

Basu, Soumya ^{[1
,2
]}

Ashok, Gayathri ^{[1
,3
]}

Debroy, Reetika ^{[4
]}

Ramaiah, Sudha ^{[1
,3
]}

Livingstone, Paul ^{[5
]}

Anbarasu, Anand ^{[1
,2
,6
]}

机构：

[1] Vellore Inst Technol VIT, Sch Biosci & Technol SBST, Med & Biol Comp Lab, Vellore, India

[2] VIT, Dept Biotechnol, SBST, Vellore, India

[3] VIT, Dept Biosci, SBST, Vellore, India

[4] VIT, Dept Biomed Sci, SBST, Vellore, India

[5] Cardiff Metropolitan Univ, Sch Sports & Hlth Sci, Cardiff, Wales

[6] Vellore Inst Technol, Sch Bio Sci & Technol, Vellore 632014, India

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2023年 / 19卷 / 01期

关键词：

COVID-19; vaccines; disruption; routine immunization; CORONAVIRUS; COVERAGE;

D O I：

10.1080/21645515.2023.2199656

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The coronavirus disease (COVID-19) threat is subsiding through extensive vaccination worldwide. However, the pandemic imposed major disruptions in global immunization programs and has aggravated the risks of vaccine-preventable disease (VPD) outbreaks. Particularly, lower-middle-income regions with minimal vaccine coverage and circulating vaccine-derived viral strains, such as polio, suffered additional burden of accumulated zero-dose children, further making them vulnerable to VPDs. However, there is no compilation of routine immunization disruptions and recovery prospects. There is a noticeable change in the routine vaccination coverage across different phases of the pandemic in six distinct global regions. We have summarized the impact of COVID-19 on routine global vaccination programs and also identified the prospects of routine immunization to combat COVID-like outbreaks.

引用

页数：8

共 43 条

[1]

Abbas K, 2020, LANCET GLOB HEALTH, V8, pE1264, DOI [10.1016/S2214-109X(20)30308-9, 10.1016/52214-109X(20)30308-9]

[2] Could Bordetella pertussis vaccine protect against coronavirus COVID-19? [J].